Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Fujii

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Schizophrenia Research|January 6, 2015
Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: a multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazoleJun Ishigooka, Jun Nakamura, Yasuo Fujii, et al.
International Clinical Psychopharmacology|January 25, 2021
Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychoticsNozomi Nakajima, Nao Mizoe, Fuminari Misawa, et al.
BMC Psychiatry|July 28, 2011
Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional studyFuminari Misawa, Keiko Shimizu, Yasuo Fujii, et al.
Biological Psychiatry|February 6, 2017
Transethnic Replication Study to Assess the Association Between Clozapine-Induced Agranulocytosis/Granulocytopenia and Genes at 12p12.2 in a Japanese PopulationTakeo Saito, Masashi Ikeda, Ryota Hashimoto, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Schizophrenia Research|January 6, 2015
Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: a multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazoleJun Ishigooka, Jun Nakamura, Yasuo Fujii, et al.
International Clinical Psychopharmacology|January 25, 2021
Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychoticsNozomi Nakajima, Nao Mizoe, Fuminari Misawa, et al.
BMC Psychiatry|July 28, 2011
Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional studyFuminari Misawa, Keiko Shimizu, Yasuo Fujii, et al.
Biological Psychiatry|February 6, 2017
Transethnic Replication Study to Assess the Association Between Clozapine-Induced Agranulocytosis/Granulocytopenia and Genes at 12p12.2 in a Japanese PopulationTakeo Saito, Masashi Ikeda, Ryota Hashimoto, et al.
Pageof 4